Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP478933.RAa5g1GupHpstJxLjuqWc6gVXLcHPvXKICCsYsFvZQXcs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP478933.RAa5g1GupHpstJxLjuqWc6gVXLcHPvXKICCsYsFvZQXcs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP478933.RAa5g1GupHpstJxLjuqWc6gVXLcHPvXKICCsYsFvZQXcs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP478933.RAa5g1GupHpstJxLjuqWc6gVXLcHPvXKICCsYsFvZQXcs130_provenance.
- NP478933.RAa5g1GupHpstJxLjuqWc6gVXLcHPvXKICCsYsFvZQXcs130_assertion description "[It would be likely that the genetic variants of the GTA3 gene encoding GAT-3, an astrocytic GABA transporter, may alter gamma-aminobutyric acid (GABA) neurotransmission in the synaptic cleft in the epileptic brain and cause antiepileptic drugs (AEDs) pharmacoresistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478933.RAa5g1GupHpstJxLjuqWc6gVXLcHPvXKICCsYsFvZQXcs130_provenance.
- NP478933.RAa5g1GupHpstJxLjuqWc6gVXLcHPvXKICCsYsFvZQXcs130_assertion evidence source_evidence_literature NP478933.RAa5g1GupHpstJxLjuqWc6gVXLcHPvXKICCsYsFvZQXcs130_provenance.
- NP478933.RAa5g1GupHpstJxLjuqWc6gVXLcHPvXKICCsYsFvZQXcs130_assertion SIO_000772 21776001 NP478933.RAa5g1GupHpstJxLjuqWc6gVXLcHPvXKICCsYsFvZQXcs130_provenance.
- NP478933.RAa5g1GupHpstJxLjuqWc6gVXLcHPvXKICCsYsFvZQXcs130_assertion wasDerivedFrom befree-20140225 NP478933.RAa5g1GupHpstJxLjuqWc6gVXLcHPvXKICCsYsFvZQXcs130_provenance.
- NP478933.RAa5g1GupHpstJxLjuqWc6gVXLcHPvXKICCsYsFvZQXcs130_assertion wasGeneratedBy ECO_0000203 NP478933.RAa5g1GupHpstJxLjuqWc6gVXLcHPvXKICCsYsFvZQXcs130_provenance.
- befree-20140225 importedOn "2014-02-25" NP478933.RAa5g1GupHpstJxLjuqWc6gVXLcHPvXKICCsYsFvZQXcs130_provenance.